We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Remote Ultrasound Platform Offers Diagnostic Scans from Anywhere

By MedImaging International staff writers
Posted on 29 Feb 2024
Print article
Image: Remote ultrasound technology promises to revolutionize diagnostic imaging (Photo courtesy of Sonus Microsystems)
Image: Remote ultrasound technology promises to revolutionize diagnostic imaging (Photo courtesy of Sonus Microsystems)

Ultrasound technology plays a significant role in the medical sector, accounting for a third of the market in medical therapeutic, surgical, and diagnostic equipment. However, the development of ultrasound transducers has been relatively stagnant, still heavily reliant on piezoelectric technology. This stagnation has created a critical need for more versatile, high-performance, and cost-effective ultrasound solutions, especially considering the reliance on sonographers' expertise. Now, a next-generation ultrasound technology capable of delivering remote diagnostic imaging without the need to go to a clinic or hospital is set to revolutionize ultrasound diagnostics.

Sonus Microsystems (Vancouver, BC, Canada) is pioneering a novel and proprietary ultrasound technology using polymer MEMS sensors for transmitting and receiving ultrasonic waves. Their transducers leverage polyCMUT technology, which stands for polymer-based Capacitive Micromachined Ultrasound Transducers. This advanced manufacturing process creates thousands of micro-vibrating drums on various substrates, significantly enhancing performance in imaging and testing applications. The polyCMUT technology marks a significant advancement in the ultrasound field, promising improved imaging capabilities and setting a new standard in diagnostic and material testing.

Sonus focuses on creating ultrasound transducers for three primary applications: disposable and miniature transducers for high-quality imaging in confined spaces; flexible and economical wearable transducers suitable for various healthcare monitoring and screening; and large matrix array transducers designed for operator-independent ultrasound imaging, facilitating remote monitoring and screening. The company's innovative matrix technology is leading the way in developing AI-powered patches that automate ultrasound scanning and measurements, offering cost-effective patient monitoring and screening solutions. Sonus has recently formed multiple partnerships in the medical field, aiming to transform the idea of remote diagnostic imaging and monitoring into reality.

“We are uniquely positioned with over 100 years of ultrasound domain expertise to deliver our cutting-edge customizable ultrasound transducers which enable automated imaging for remote monitoring and wearable ultrasound applications powered by AI diagnosis,” said Dr. Hani Eskandari, CEO and President at Sonus Microsystems.

"Our transducers have demonstrated superb performance for medical diagnostic applications requiring a high degree of design flexibility," added Dr. Carlos D. Gerardo, Co-Founder and Director of R&D. "By utilizing polymers, we can manufacture polyCMUTs with fewer fabrication steps and minimal equipment, leading to substantial cost savings, swift iteration cycles, and unique capabilities."

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Computed Tomography (CT) Scanner
Aquilion Serve SP
New
Mobile Digital C-arm X-Ray System
HHMC-200D
Ultrasound System
Acclarix AX9

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.